From our sister publication, Managed Healthcare Executive: Experts revealed at the
recent Pharmaceutical Care Management Association Annual Meeting how access and costs of gene therapies, curatives, and ultra-orphan drugs will be managed.
This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.
This email was sent by: MultiMedia Healthcare
535 Connecticut Avenue, Suite 300
Norwalk, CT, 06854, USA